跳至主要内容
临床试验/ISRCTN04176397
ISRCTN04176397
已完成
不适用

Procalcitonin guided reduction of the duration of antibiotic therapy in Community Acquired Pneumonia

niversity Hospital Basel (Switzerland)0 个研究点目标入组 250 人2005年2月15日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Community Acquired Pneumonia (CAP)
发起方
niversity Hospital Basel (Switzerland)
入组人数
250
状态
已完成
最后更新
11年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2005年2月15日
结束日期
待定
最后更新
11年前
研究类型
Interventional
性别
All

研究者

发起方
niversity Hospital Basel (Switzerland)

入排标准

入选标准

  • The criterion for inclusion in the study was a suspected CAP as the main diagnosis. This was defined as presence of a new infiltrate on chest X\-ray accompanied by one or several acquired respiratory symptoms and signs:
  • 2\. Sputum production
  • 3\. Dyspnoea
  • 4\. Fever over 38\.0°C
  • 5\. Auscultatory findings of abnormal breath sounds and rales
  • 6\. Leukocytosis more than 10 x 10^9 cells/L or leukopenia less than 4 x 10^9 cells/L in the absence of a hospital stay within 14 days before admission

排除标准

  • 1\. Cystic fibrosis or active tuberculosis
  • 2\. Immunocompromised patients, i.e. patients infected with Human Immunodeficiency Virus (HIV) infection and a CD4 count below 200
  • 3\. Neutropenic patients with a neutrophil count less than 500 x 10^9/ml
  • 4\. Under chemotherapy with neutrophils 500 \- 1000 x 10^9/ml with an expected decrease to values less than 500 x 10^9/ml
  • 5\. Immunosuppressive therapy after bone marrow or solid organ transplantation
  • 6\. Nosocomial pneumonia

结局指标

主要结局

未指定

相似试验